VSee Health’s (VSEE) “Sell (E+)” Rating Reiterated at Weiss Ratings

Weiss Ratings reissued their sell (e+) rating on shares of VSee Health (NASDAQ:VSEE) in a research report sent to investors on Friday,Weiss Ratings reports.

VSee Health Trading Down 7.1%

Shares of VSee Health stock opened at $0.62 on Friday. The stock’s fifty day moving average price is $0.68 and its 200-day moving average price is $1.00. The firm has a market cap of $2.24 million and a P/E ratio of -0.57. VSee Health has a 12 month low of $0.46 and a 12 month high of $3.54.

VSee Health (NASDAQ:VSEE) last released its quarterly earnings data on Wednesday, October 15th. The company reported ($0.14) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.02). VSee Health had a negative return on equity of 146.51% and a negative net margin of 461.61%.The business had revenue of $3.39 million during the quarter, compared to analysts’ expectations of $3.90 million.

Institutional Trading of VSee Health

Hedge funds have recently modified their holdings of the company. HB Wealth Management LLC purchased a new stake in shares of VSee Health during the 3rd quarter valued at $368,000. Osaic Holdings Inc. increased its holdings in shares of VSee Health by 197.5% during the second quarter. Osaic Holdings Inc. now owns 45,170 shares of the company’s stock valued at $52,000 after acquiring an additional 29,985 shares in the last quarter. Finally, XTX Topco Ltd acquired a new position in shares of VSee Health during the first quarter valued at about $34,000. 1.01% of the stock is owned by hedge funds and other institutional investors.

About VSee Health

VSee Health, Inc is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.